ReviewFrontiers in cell and developmental biology2026
Advancing the frontiers of phytotherapy: a comprehensive review of botanical interventions targeting mitochondrial quality control to ameliorate endometriosis.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Do Oxidative Stress-Modified Exosomes Contribute to Infertility in Endometriosis?International journal of molecular sciences · 2026Review
- Therapeutic Potential ofInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometriosis (EMs) is a gynecological disorder affecting women of reproductive age. It is characterized by the ectopic implantation and infiltration of endometrial-like tissue and is associated with significant effects on fertility, pelvic function, and overall wellbeing. Clinically, it presents with progressive secondary dysmenorrhea, chronic pelvic pain, and infertility, leading to a substantial reduction in quality of life. Despite decades of research, the pathogenesis of EMs remains complex and is driven by interacting hormonal, immunological, inflammatory, and metabolic factors. Current treatment approaches, including hormonal suppression and surgical excision, provide only temporary relief and are associated with systemic side effects, functional limitations, and high recurrence rates. These limitations highlight the need for safer and more effective therapeutic strategies. Mitochondria play a central role in the development of EMs. Mitochondrial function is regulated by the mitochondrial quality control (MQC) system, which consists of several interconnected processes, including redox homeostasis, mitochondrial fission and fusion, mitophagy, biogenesis, and calcium signaling. Increasing evidence suggests that disruption of MQC is not merely a secondary effect but a key contributor to EMs pathogenesis. MQC dysfunction enables ectopic endometrial cells to evade apoptosis, promotes invasive proliferation, supports oxidative stress adaptation, and facilitates survival in unfavorable microenvironments. Plant-derived compounds have gained attention as potential modulators of MQC. These compounds exhibit multi-target effects, favorable safety profiles, and a wide range of bioactive structures. Experimental studies indicate that botanical agents, including flavonoids and terpenoids, can regulate multiple components of the MQC system. They reduce mitochondrial reactive oxygen species, modulate DRP1/OPA1-mediated mitochondrial dynamics, enhance PINK1-Parkin-dependent mitophagy, promote PGC-1α-mediated mitochondrial biogenesis, and maintain calcium homeostasis. Through these mechanisms, phytochemicals improve mitochondrial function, inhibit abnormal cell survival signaling, induce apoptosis in ectopic lesions, and contribute to the restoration of endometrial homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.